haloperidol and 1,2,3,6-tetrahydro-4-phenyl-1-((3-phenyl-3-cyclohexen-1-yl)methyl)pyridine

haloperidol has been researched along with 1,2,3,6-tetrahydro-4-phenyl-1-((3-phenyl-3-cyclohexen-1-yl)methyl)pyridine in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Caprathe, BW; Downing, DM; Glase, SA; Heffner, TG; Jaen, JC; Johnson, SJ; Kesten, SR; MacKenzie, RG; Meltzer, LT; Wright, JL	1
Fang, X; Hu, Z; Levant, B; Min, J; Varady, J; Wang, S; Wu, X	1

Other Studies

2 other study(ies) available for haloperidol and 1,2,3,6-tetrahydro-4-phenyl-1-((3-phenyl-3-cyclohexen-1-yl)methyl)pyridine

Article	Year
The discovery and structure-activity relationships of 1,2,3,6-tetrahydro-4-phenyl-1-[(arylcyclohexenyl)alkyl]pyridines. Dopamine autoreceptor agonists and potential antipsychotic agents. Journal of medicinal chemistry, 1994, Oct-14, Volume: 37, Issue:21 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Action Potentials; Animals; Antipsychotic Agents; Avoidance Learning; Brain; CHO Cells; Cricetinae; Crystallography, X-Ray; Cyclic AMP; Cyclohexanes; Cyclohexenes; Dopamine; Dopamine Agonists; Mice; Models, Molecular; Molecular Structure; Motor Activity; Pyridines; Rats; Receptors, Dopamine; Saimiri; Stereoisomerism; Structure-Activity Relationship; Substantia Nigra	1994
Molecular modeling of the three-dimensional structure of dopamine 3 (D3) subtype receptor: discovery of novel and potent D3 ligands through a hybrid pharmacophore- and structure-based database searching approach. Journal of medicinal chemistry, 2003, Oct-09, Volume: 46, Issue:21 Topics: Algorithms; Binding Sites; Computational Biology; Crystallography, X-Ray; Databases, Protein; Humans; Kinetics; Ligands; Lipid Bilayers; Models, Molecular; Molecular Conformation; Mutation; Receptors, Dopamine D2; Receptors, Dopamine D3; Reproducibility of Results; Solvents; Structure-Activity Relationship; Tetrahydronaphthalenes; Water	2003

Article

Year

The discovery and structure-activity relationships of 1,2,3,6-tetrahydro-4-phenyl-1-[(arylcyclohexenyl)alkyl]pyridines. Dopamine autoreceptor agonists and potential antipsychotic agents.

Journal of medicinal chemistry, 1994, Oct-14, Volume: 37, Issue:21

Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Action Potentials; Animals; Antipsychotic Agents; Avoidance Learning; Brain; CHO Cells; Cricetinae; Crystallography, X-Ray; Cyclic AMP; Cyclohexanes; Cyclohexenes; Dopamine; Dopamine Agonists; Mice; Models, Molecular; Molecular Structure; Motor Activity; Pyridines; Rats; Receptors, Dopamine; Saimiri; Stereoisomerism; Structure-Activity Relationship; Substantia Nigra

1994

Molecular modeling of the three-dimensional structure of dopamine 3 (D3) subtype receptor: discovery of novel and potent D3 ligands through a hybrid pharmacophore- and structure-based database searching approach.

Journal of medicinal chemistry, 2003, Oct-09, Volume: 46, Issue:21

Topics: Algorithms; Binding Sites; Computational Biology; Crystallography, X-Ray; Databases, Protein; Humans; Kinetics; Ligands; Lipid Bilayers; Models, Molecular; Molecular Conformation; Mutation; Receptors, Dopamine D2; Receptors, Dopamine D3; Reproducibility of Results; Solvents; Structure-Activity Relationship; Tetrahydronaphthalenes; Water

2003